IQVIA Holdings Inc. (IQV)
USD 153.48
(1.58%)
USD 153.48
(1.58%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 14.23 Billion USD | 9.38% |
| 2022 | 13.01 Billion USD | 4.61% |
| 2021 | 12.43 Billion USD | -3.61% |
| 2020 | 12.9 Billion USD | 7.17% |
| 2019 | 12.04 Billion USD | 9.39% |
| 2018 | 11 Billion USD | 7.65% |
| 2017 | 10.22 Billion USD | 42.01% |
| 2016 | 7.2 Billion USD | 191.76% |
| 2015 | 2.46 Billion USD | 7.61% |
| 2014 | 2.29 Billion USD | 12.09% |
| 2013 | 2.04 Billion USD | -15.52% |
| 2012 | 2.42 Billion USD | 22.83% |
| 2011 | 1.97 Billion USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 13.51 Billion USD | 1.86% |
| 2024 Q2 | 13.45 Billion USD | -2.11% |
| 2024 Q1 | 13.74 Billion USD | -3.45% |
| 2023 Q2 | 14.01 Billion USD | 4.38% |
| 2023 Q3 | 13.84 Billion USD | -1.22% |
| 2023 Q4 | 14.23 Billion USD | 2.77% |
| 2023 FY | 14.23 Billion USD | 9.38% |
| 2023 Q1 | 13.43 Billion USD | 3.23% |
| 2022 Q1 | 12.94 Billion USD | 4.09% |
| 2022 FY | 13.01 Billion USD | 4.61% |
| 2022 Q2 | 13.05 Billion USD | 0.81% |
| 2022 Q4 | 13.01 Billion USD | 2.83% |
| 2022 Q3 | 12.65 Billion USD | -3.06% |
| 2021 Q3 | 12.49 Billion USD | -1.08% |
| 2021 Q2 | 12.63 Billion USD | 0.39% |
| 2021 Q1 | 12.58 Billion USD | -2.49% |
| 2021 FY | 12.43 Billion USD | -3.61% |
| 2021 Q4 | 12.43 Billion USD | -0.46% |
| 2020 Q4 | 12.9 Billion USD | 1.4% |
| 2020 FY | 12.9 Billion USD | 7.17% |
| 2020 Q1 | 12.39 Billion USD | 2.97% |
| 2020 Q2 | 12.5 Billion USD | 0.89% |
| 2020 Q3 | 12.72 Billion USD | 1.73% |
| 2019 Q2 | 11.79 Billion USD | 0.93% |
| 2019 Q3 | 11.93 Billion USD | 1.17% |
| 2019 Q1 | 11.68 Billion USD | 6.19% |
| 2019 FY | 12.04 Billion USD | 9.39% |
| 2019 Q4 | 12.04 Billion USD | 0.89% |
| 2018 Q2 | 10.72 Billion USD | 2.7% |
| 2018 FY | 11 Billion USD | 7.65% |
| 2018 Q4 | 11 Billion USD | 3.65% |
| 2018 Q3 | 10.61 Billion USD | -1.02% |
| 2018 Q1 | 10.44 Billion USD | 2.16% |
| 2017 Q1 | 8.34 Billion USD | 15.9% |
| 2017 FY | 10.22 Billion USD | 42.01% |
| 2017 Q4 | 10.22 Billion USD | 4.83% |
| 2017 Q3 | 9.75 Billion USD | 8.96% |
| 2017 Q2 | 8.95 Billion USD | 7.27% |
| 2016 FY | 7.2 Billion USD | 191.76% |
| 2016 Q4 | 7.2 Billion USD | 195.61% |
| 2016 Q3 | 2.43 Billion USD | -0.44% |
| 2016 Q2 | 2.44 Billion USD | -0.44% |
| 2016 Q1 | 2.45 Billion USD | -0.43% |
| 2015 Q3 | 2.47 Billion USD | -0.44% |
| 2015 Q2 | 2.48 Billion USD | 8.51% |
| 2015 Q1 | 2.29 Billion USD | 0.04% |
| 2015 FY | 2.46 Billion USD | 7.61% |
| 2015 Q4 | 2.46 Billion USD | -0.43% |
| 2014 Q2 | 2.04 Billion USD | 0.04% |
| 2014 Q3 | 2.04 Billion USD | -0.21% |
| 2014 Q1 | 2.04 Billion USD | 0.04% |
| 2014 FY | 2.29 Billion USD | 12.09% |
| 2014 Q4 | 2.29 Billion USD | 12.24% |
| 2013 Q3 | 2.04 Billion USD | 0.04% |
| 2013 FY | 2.04 Billion USD | -15.52% |
| 2013 Q2 | 2.04 Billion USD | -14.41% |
| 2013 Q1 | 2.38 Billion USD | -1.34% |
| 2013 Q4 | 2.04 Billion USD | -0.0% |
| 2012 FY | 2.42 Billion USD | 22.83% |
| 2012 Q4 | 2.42 Billion USD | 0.0% |
| 2011 FY | 1.97 Billion USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Agilent Technologies, Inc. | 2.73 Billion USD | -420.329% |
| Charles River Laboratories International, Inc. | 3.06 Billion USD | -364.098% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | -165.059% |
| Danaher Corporation | 19.53 Billion USD | 27.155% |
| Enzo Biochem, Inc. | 265 Thousand USD | -5370088.679% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | -139.008% |
| Mettler-Toledo International Inc. | 2.08 Billion USD | -583.907% |
| Qiagen N.V. | 1.61 Billion USD | -783.296% |
| Revvity, Inc. | 4.03 Billion USD | -252.917% |
| Thermo Fisher Scientific Inc. | 34.91 Billion USD | 59.243% |
| Waters Corporation | 2.35 Billion USD | -504.157% |